The Hindu Business Line : Ranbaxy launches liquid form of diabetes drug in US

RANBAXY Laboratories Ltd (Ranbaxy) has launched the liquid form of Metformin used to treat Type 2 diabetes called RiometTM (Metformin HCl oral solution) 500 mg/ml, in the US market.

Type 2 diabetes is the seventh leading cause of death in the US. According to a company statement, as a liquid form of Metformin, RiometTM may significantly improve the lives of people with diabetes who are unable to swallow tablets — a condition known as dysphagia. Dysphagia is a relatively unknown but widespread problem, affecting one in 17 people in some form.

Mr Jeffrey Thomas, Vice-President, Brand Marketing and Sales at Ranbaxy USA Inc and affiliate of Ranbaxy Pharmaceuticals Inc ( RPI is a wholly owned subsidiary of Ranbaxy) said, "At Ranbaxy we recognised that non-compliance with treatment is a major problem among people with type 2 diabetes. Only one-third control their blood sugar. For that reason, and the large number of people who have difficulty swallowing large tablets, we saw an opportunity for a liquid form of the top-selling diabetes drug Metformin."

More Stories on : Announcements | New Products & Services | Pharmaceuticals | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Ranbaxy launches liquid form of diabetes drug in US

Dubai Cable bags Delhi Metro contract

After 25 years, ICAI revises accounting norms `Preface'

Ashok Leyland may make pref offer to promoters

Zee Tele plans to raise $100 m through FCCBs

Dishman to tap market to support outsourcing

Hindustan Paper plans to convert wastes into energy

Ester Industries Q3 net at Rs 13.62 cr

Over 100 cos to participate in IIMB campus placements

Panel to look into sops for Dabhol revival

Marico banks on value-addition for growth

Corolla races ahead, but competition hots up

SABMiller CEO visiting India